BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9023789)

  • 1. Hostility changes following antidepressant treatment: relationship to stress and negative thinking.
    Fava M; Davidson K; Alpert JE; Nierenberg AA; Worthington J; O'Sullivan R; Rosenbaum JF
    J Psychiatr Res; 1996; 30(6):459-67. PubMed ID: 9023789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment.
    Fava M; Rosenbaum JF; Pava JA; McCarthy MK; Steingard RJ; Bouffides E
    Am J Psychiatry; 1993 Aug; 150(8):1158-63. PubMed ID: 7848377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment.
    Farabaugh A; Sonawalla S; Johnson DP; Witte J; Papakostas GI; Goodness T; Clain A; Baer L; Mischoulon D; Fava M; Harley R
    Ann Clin Psychiatry; 2010 Aug; 22(3):166-71. PubMed ID: 20680189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sociodemographic predictors of response to antidepressant treatment.
    Spillmann M; Borus JS; Davidson KG; Worthington JJ; Tedlow JR; Fava M
    Int J Psychiatry Med; 1997; 27(2):129-36. PubMed ID: 9565719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine].
    Dalery J; Bouhassira M; Kress JP; Lancrenon S; Tafani A; Hantouche EG
    Encephale; 1995; 21(3):217-25. PubMed ID: 7649072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality disorder comorbidity with major depression and response to fluoxetine treatment.
    Fava M; Bouffides E; Pava JA; McCarthy MK; Steingard RJ; Rosenbaum JF
    Psychother Psychosom; 1994; 62(3-4):160-7. PubMed ID: 7846259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunctional attitudes in major depression. Changes with pharmacotherapy.
    Fava M; Bless E; Otto MW; Pava JA; Rosenbaum JF
    J Nerv Ment Dis; 1994 Jan; 182(1):45-9. PubMed ID: 8277301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.
    Strik JJ; Honig A; Lousberg R; Lousberg AH; Cheriex EC; Tuynman-Qua HG; Kuijpers PM; Wellens HJ; Van Praag HM
    Psychosom Med; 2000; 62(6):783-9. PubMed ID: 11138997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression.
    Pedrelli P; Feldman GC; Vorono S; Fava M; Petersen T
    Psychiatry Res; 2008 Dec; 161(3):302-8. PubMed ID: 18976817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.
    Simon GE; Heiligenstein JH; Grothaus L; Katon W; Revicki D
    J Clin Psychiatry; 1998 Feb; 59(2):49-55. PubMed ID: 9501885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting response to fluoxetine in geriatric patients with major depression.
    Koran LM; Hamilton SH; Hertzman M; Meyers BS; Halaris AE; Tollefson GD; Downs JM; Folks DG; Jeste DV; Lazarus LW
    J Clin Psychopharmacol; 1995 Dec; 15(6):421-7. PubMed ID: 8748431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antidepressants on thinking styles in depressed inpatients.
    Telner J; Surphlis W; Lapierre Y; Mehta G
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):277-84. PubMed ID: 3290998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality disorders and depression.
    Fava M; Farabaugh AH; Sickinger AH; Wright E; Alpert JE; Sonawalla S; Nierenberg AA; Worthington JJ
    Psychol Med; 2002 Aug; 32(6):1049-57. PubMed ID: 12214786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled comparison of milnacipran and fluoxetine in major depression.
    Ansseau M; Papart P; Troisfontaines B; Bartholomé F; Bataille M; Charles G; Schittecatte M; Darimont P; Devoitille JM; De Wilde J
    Psychopharmacology (Berl); 1994 Feb; 114(1):131-7. PubMed ID: 7846195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.